Morgan Stanley Remains a Hold on Qube Holdings (1K1)
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks, Koh is a 3-star analyst with an average return of 2.3% and a 52.05% success rate. Koh covers the Energy sector, focusing on stocks such as Origin Energy Limited, Ampol Limited, and Santos Limited.
Qube Holdings has an analyst consensus of Moderate Buy, with a price target consensus of €2.51, representing a 6.36% upside. In a report released on July 14, RBC Capital also maintained a Hold rating on the stock with a A$4.30 price target.
1K1 market cap is currently €4.2B and has a P/E ratio of 30.69.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Howmet Aerospace Stock Hits All-Time Highs, Analysts Eye Further Gains
Howmet Aerospace Inc. (NYSE:HWM) stock recently hit new all-time and 52-week highs, driven by strong market momentum and bullish analyst sentiment. HWM has a 52‑week high of $189.48 and a 52‑week low of $77.22. The stock is now up around 72.6% year‑to‑date and is trading roughly 10% above its 50‑day simple moving average. Analysts remain bullish. Morgan Stanley's Kristine Liwag reaffirmed her Overweight rating on HWM and raised the price forecast from $170 to $210. Also Read: Susquehanna's Charles Minervino also maintained a Positive rating and lifted his forecast to $210 from $170. Earlier in July, analysts at RBC and Truist raised their price forecasts to $200 and $192, respectively, citing robust aerospace demand and operational improvements. The company had also boosted its full-year guidance following strong first-quarter results, with EPS up 51% year over year. Howmet is scheduled to report second-quarter earnings on July 29. In late June, the CEO received a $45 million retention grant in the form of 255,363 restricted stock units (RSUs), scheduled to vest in 2028. A Form 4 filing confirmed the award, while his $1.8 million base salary and bonus eligibility remain unchanged. Price Action: HWM shares are trading higher by 0.78% to $190.28 at last check Friday. Read Next:Photo by T. Schneider via Shutterstock Latest Ratings for HWM Date Firm Action From To Feb 2022 Keybanc Maintains Overweight Feb 2022 Morgan Stanley Maintains Overweight Dec 2021 Keybanc Maintains Overweight View More Analyst Ratings for HWM View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Howmet Aerospace Stock Hits All-Time Highs, Analysts Eye Further Gains originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Snowflake initiated, Chipotle upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The 5 Upgrades: BMO Capital upgraded Chipotle (CMG) to Outperform from Market Perform with a price target of $65, up from $56. The firm believes Chipotle is well positioned for accelerating comparable sales growth and improving margins beginning in the second half of 2025, Jefferies upgraded Abbott (ABT) to Buy from Hold with a price target of $145, up from $143. The firm says that while Abbott's Q2 report and outlook were "underwhelming," the corresponding share selloff is "too punitive." Raymond James upgraded Synovus (SNV) to Outperform from Market Perform with a $62 price target. The bank's Q2 results exceeded estimates, and it increased the majority of its 2025 outlook, the firm tells investors in a research note. Keefe Bruyette also upgraded Synovus to Outperform from Market Perform. Guggenheim upgraded Cognizant (CTSH) to Buy from Neutral with a $90 price target. The firm says its checks in the channel signaled strength driven by new wins for Cognizant and strength outside of North America. Morgan Stanley upgraded Topgolf Callaway (MODG) to Equal Weight from Underweight with a price target of $9.50, up from $6, following transfer in analyst coverage. The firm views Topgolf Callaway as a premier golf equipment and active lifestyle franchise clouded by high leverage and underperformance at TopGolf and believes the market is ascribing "negative or no value to TopGolf at present." Top 5 Downgrades: Leerink downgraded Elevance Health (ELV) to Market Perform from Outperform with a price target of $310, down from $510, seeing limited upside in the stock. The firm downgraded Elevance citing its belief that the company will have "no apparent earnings growth" in 2026, "no meaningful investment case for improving sentiment and sector valuations," and "lingering, potential, and accelerating risks across almost all lines of business and products." Jefferies downgraded Matson (MATX) to Hold from Buy with a price target of $115, down from $135. The firm expects Matson to report Q2 results better than expectations, but says the company's outlook for Q3 "looks to be softer." Evercore ISI downgraded Rexford Industrial (REXR) to In Line from Outperform with a price target of $38, down from $39, post the Q2 report. The firm continues to believe in the long-term value proposition of the Sothern California industrial market, but says a recovery in rents is pushed out longer than expected. DA Davidson downgraded BlueLinx (BXC) to Neutral from Buy with an $80 price target. "Misguided" takeover speculation, paired with continued weak market fundamentals leave a less attractive risk/reward, the firm tells investors in a research note. H.C. Wainwright downgraded Clearside Biomedical (CLSD) to Neutral from Buy without a price target after the company said it was exploring strategic alternatives. No agreement for any strategic transaction has been reached and no timetable has been set for the strategic review process, the firm tells investors in a research note. Top 5 Initiations: Stephens initiated coverage of Snowflake (SNOW) with an Overweight rating and $261 price target. The firm views artificial intelligence as a "large growth acceleration opportunity" for Snowflake. Rosenblatt initiated coverage of SentinelOne (S) with a Buy rating and $24 price target. The firm believes the company is undervalued considering "its strategic position as a leader in AI-driven cybersecurity," noting that it trades at an approximate 40% discount to its peers. Rosenblatt initiated coverage of Verint (VRNT) with a Buy rating and $40 price target. The firm believes the company is significantly undervalued given the company's broad AI portfolio and the inherent competitive advantage that the company holds having more than a decade of data from interactions to train advanced AI models. Stephens initiated coverage of MongoDB (MDB) with an Equal Weight rating and $247 price target. The firm has competition concerns but views MongoDB's Atlas as a "rare, high-quality asset." Evercore ISI initiated coverage of Ralliant (RAL) with an In Line rating and $52 price target. While the firm sees "potential for sizable upside for the stock," it needs to see a path to revenue growth in aggregate and says its rating reflects secular end-market growth trends and "shareholder friendly capital allocation," offset by declines in the Test & Measurement segment. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Big Banks Q2 Earnings Thrive: ETFs in Focus
Interest rates remain elevated, trade tensions remain in place, and markets have been on a wild ride — yet the largest banks of the United States continue to post strong results. While retail investors may find the volatility unsettling — particularly those needing to liquidate equities or seeking quick gains — Wall Street banks are benefiting. In the second quarter, the five largest U.S. banks reported a collective 17% rise in trading revenues and a 7% increase in investment banking revenues compared to the same quarter last year (read: Banks Lift Payouts Amid Successful Stress Test: ETFs in Focus). Volatility Fuels Trading Desks For banks' equities trading desks, volatility isn't a threat — it's a business driver. Their profits don't hinge on whether markets rise or fall, but on the volume and frequency of trades. As stock prices swung dramatically this quarter, banks reaped the rewards from elevated trading activity. Retail investors may have been whipsawed by rapid market moves — reacting to everything from tariff announcements to geopolitical conflicts like Israel-Iran — but banks were there to facilitate trades and collect fees at every turn. Diversification is Key This quarter reinforces the resilience and flexibility of financial services firms. Whether interest rates stay high or the economy faces headwinds, diversified banking operations — from trading to investment advisory — helped banks thrive. Trade Uncertainty Isn't Slowing Deals Despite ongoing tariff threats and policy unpredictability, banks report that corporate clients remain undeterred. Companies are still pursuing mergers, issuing debt and going public. Bank executives this week emphasized that strategic initiatives are moving forward, regardless of short-term trade risks. Banking Earnings in Focus Morgan Stanley's (MS) second-quarter 2025 earnings per share of $2.13 handily surpassed the Zacks Consensus Estimate of $1.93. The figure also compared favorably with $1.82 per share reported in the prior-year quarter. Additionally, Morgan Stanley's net revenues of $16.79 billion were up 12% from the prior-year quarter and beat the Zacks Consensus Estimate of $15.92 billion. Morgan Stanley's strong trading business performance was propelled by higher client activity, with strength in equity trading. The company's equity trading revenues jumped 23% year over year to $3.72 billion, and fixed-income trading income was up 9% to $2.18 billion. Similarly, the trading business led to windfall gains for Goldman Sachs GS and JPMorgan JPM. Goldman reported Q2 EPS of $10.91, beating the estimate of $9.43 and rising from $8.62 a year Banking and Markets revenues rose 24% to $10.1B, led by equities and FICC trading raised its quarterly dividend 33.3% to $4.00 per share after clearing the 2025 Fed stress test. JPMorgan came out with quarterly earnings of $4.96 per share, beating the Zacks Consensus Estimate of $4.51 per share. This compares to earnings of $4.4 per share a year ago. Revenues of $44.91 billion topped the Zacks Consensus Estimate by 2.52%. Wells Fargo & Company's WFC second-quarter 2025 adjusted earnings per share of $1.54 surpassed the Zacks Consensus Estimate of $1.41. In the prior-year quarter, the company reported earnings per share of $1.33. Fee income rose 4% on a gain from the merchant services JV acquisition. Citigroup Inc. C reported second-quarter 2025 adjusted net income per share of $1.96, up 28.9% from the year-ago period. The metric also surpassed the Zacks Consensus Estimate by 21.7%. Bank ETFs in Focus Against this backdrop, financials-based exchange-traded funds (ETFs), such as iShares U.S. Financial Services ETF IYG, iShares US Financials ETF IYF, Invesco KBW Bank ETF KBWB, Financial Select Sector SPDR XLF and Vanguard Financials ETF VFH should gain ahead. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Goldman Sachs Group, Inc. (GS) : Free Stock Analysis Report Wells Fargo & Company (WFC) : Free Stock Analysis Report JPMorgan Chase & Co. (JPM) : Free Stock Analysis Report Citigroup Inc. (C) : Free Stock Analysis Report Financial Select Sector SPDR ETF (XLF): ETF Research Reports Invesco KBW Bank ETF (KBWB): ETF Research Reports iShares U.S. Financial Services ETF (IYG): ETF Research Reports Vanguard Financials ETF (VFH): ETF Research Reports iShares U.S. Financials ETF (IYF): ETF Research Reports This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
